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8. Because of the initial presence of late succes-
sional organisms, the ecological succession was 
not a case of facilitation. It therefore would be 
classified under the neutral (tolerance) or inhibi-
tion models of J. H. Connell and R. O. Slatyer 
[Am. Nat. 111, 1119 (1977)J. M. J. Keough 
[Ecology 65, 423 (1984)] showed that recruit-
ment was a much more important process than 
interference competition on small isolated 
patches, so that the neutral model of succession 
is most plausible here. 
9. T . J. Palmer and C. D. Palmer [Lethaia 10, 197 
(1977)] discussed the morphological and evolu-
tionary effects of scour on a Middle Ordovician 
hardground community . M. A. Wilson [ibid. IS , 
263 (1982)J described a Pennsylvanian brachio-
pod-bryozoan ecosystem in which diversity was 
gradually enhanced by the accumulation of bio-
genic debris . 
10. I thank G. M. Wil son, W. P. Sousa, M . J. 
James, and G. G. Whitney for reviewing this 
manuscript, and J. W. Bartley for bryozoan 
identification. Supported by grants from Sigma 
Xi and College of Wooster. 
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Expression of a Microinjected Porcine Class I Major 
Histocompatibility Complex Gene in Transgenic Mice 
Abstract. A porcine class I major histocompatibility complex (SLA) gene has been 
introduced into the genome ofa C57BLiJO mouse. This transgenic mouse expressed 
SLA antigen on its cell surfaces and transmitted the gene to offspring, in which the 
gene is also expressed. Skin grafts of such transgenic mice were rejected by normal 
C57BLi 10 mice, suggesting that the foreign SLA antigen expressed in the transgenic 
mice is recognized as a functional transplantation antigen . 
The introduction of isolated class I 
major histocompatibility complex 
(MHC) genes into cultured mammalian 
cells has been used to study their expres-
sion, antigenicity, and antigen-present-
ing capacity (1). This approach allows 
the introduction of genes not normally 
expressed in the recipient cell, such as 
foreign, mutant, or hybrid MHC genes 
constructed in vitro (2, 3). In addition, 
the expression of individual members of 
a mul!.igene family can be studied in 
isolation. 
However, such studies have been gen-
erally limited to a small number of cell 
types, such as L cells, and the questions 
addressed have been limited to those 
related to the expression of the intro-
duced gene in that particular cellular 
environment. It has not been possible to 
address developmental issues such as 
the patterns of tissue-specific expression 
of individual class I MHC genes or the 
influence of newly introduced genes on 
the induction of self tolerance and the 
maturation of the immune response . To 
study these unanswered questions, we 
microinjected a cloned xenogeneic class 
I MHC gene into the fertilized eggs of 
mice. We now report the identification of 
a transgenic mouse that expresses a por-
cine class I MHC gene that can be trans-
mitted to progeny, in which it is also 
expressed. 
itation. The latter studies also revealed 
that the SLA heavy chain associates 
with the endogenous murine 02-micro-
globulin of the L cell. Further studies 
indicated that the expression of the 
swine MHC gene was actively regulated 
(4). In addition, the swine DNA and 
RNA sequences as well as the protein 
products were readily distinguishable 
from the endogenous murine sequences . 
Therefore, this gene seemed to be an 
ideal candidate for microinjection ex-
periments. 
Male pronuclei of one-cell CS7BLI 
lOSCN (B 10) fertilized eggs were inject-
ed either with approximately SOO copies 
of a 9-kilobase (kb) Hind III fragment 
derived directly from the PDl clone or 
with about 2000 copies of a S.6-kb Hind 
III-Bam HI fragment, subcloned into 
pBR322 and linearized with either Hind 
III or Eco RI (Fig. 1) . These fragments 
of swine DNA each contain the entire 
SLA gene and have been shown to direct 
the synthesis of SLA antigen in mouse L 
cells (5). Of 171 eggs injected with the 
S.6-kb Hind III-Bam HI DNA fragment , 
100 were transferred to pseudopregnant 
Sim:SW females, and there were 63 off-
spring. Twenty-seven eggs were injected 
with the 9-kb Hind III DNA fragment, 
~3.4_ 
and 20 were transferred to a single foster 
mother ; there were five offspring. 
In testing for the swine DNA se-
quences, DNA was extracted from a 
segment of tail of each of the mice and 
hybridized with an SLA DNA probe 
(Fig. I) under conditions in which only 
SLA DNA sequences, but not endoge-
nous H-2 sequences, would hybridize . A 
single SLA-positive mouse (3931), which 
had been injected as an embryo with the 
swine 9-kb Hind III DNA fragment , was 
identified by dot blot analysis. For fur-
ther verification of the SLA gene in 
animal 3931, total tail DNA was digested 
with the restriction enzyme Bgi II . This 
enzyme releases three SLA coding-se-
quence DNA fragments of 2.9, 1.8, and 
0.9 kb from the intact gene (Fig. I). 
Therefore, it was expected that all three 
of these bands would be present in the 
DNA of animal 3931 but not in the DNA 
of its negative Iittermates . The SLA 
probe hybridized specifically to appro-
priately sized DNA fragments from ani-
mal 3931 and pig liver but not to those 
from negative Iittermates or normal B 10 
animals. This confirms the presence of 
the SLA gene in animal 3931. 
The ability of the SLA gene to be 
expressed in the transgenic mouse was 
assessed by cell-surface labeling of pe-
ripheral blood lymphocytes (PBL's) with 
a monoclonal antibody specific for SLA 
determinants (6), which does not cross-
react with murine class I MHC antigens. 
This monoclonal antibody has been 
shown to react specifically with L cells 
transfected with either the whole PDI 
DNA or the Hind III 9-kb DNA frag-
ment but not with control L cells (4, 5). 
PBL's from animal 3931 and normal BlO 
mice were stained with biotin-conjugated 
antibody to SLA. Binding of the mono-
clonal antibody was assessed with 
fluoresceinated avidin, which binds to 
biotinylated antibody on the cell surface . 
The antibody to SLA reacted specifically 
with PBL from animal 3931 (Fig. 2a). In 
contrast, lymphocytes from normal B 10 
animals were not stained above back-
ground levels by this reagent (Fig. 2b). 
In efforts to examine the stability of 
expression and heritability of the SLA 
• I Hind III ? Bam HI 
~ Sac I 
Fig. I. Partial restriction map 
of PD I, which contains a func-
tional SLA gene (shaded area) 
(3). The 5.6-kb swine DNA 
fragment subcloned into 
pBR322 and used in microin-
jection (I), the 9-kb Hind III 
_-------.-.. II ,. I _____ · ___ ~ III Bgi II 
Earlier we showed that the introduc-
tion of PD1, a porcine' genomic clone 
containing a class I MHC (SLA) gene, 
into mouse L cells by DNA-mediated 
gene transfer resulted in the cell-surface 
expression of SLA antigen (3), as detect-
ed by antibody-mediated, complement-
dependent cytotoxicity, cell-surface im-
munofluorescence, and immunoprecip-
swine DNA fragment used in 
microinjection (II), the 2.5-kb Sac I-Bam HI DNA fragment used as an SLA-specific probe in 
hybridization experiments, and the origins of the hybridizing 3.4-kb Sac I fragment and of the 
2.95-, 1.95-, and O.9-kb Bgl II fragments are noted (see Fig. 3). 
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gene and to estimate the number of loci 
into which the SLA gene integrated, 
animal 3931 was mated to B 10 females. 
Initially, 30 offspring were tested for the 
presence of the SLA gene by hybridiza-
tion of tail DNA with the SLA-specific 
probe and for gene expression by cell-
surface staining of PBL with SLA-spe-
cific antibodies. All mice scored as posi-
tive for SLA DNA by hybridization ex-
pressed SLA antigen. Furthermore, 
mice that did not contain SLA DNA 
sequences did not express SLA antigen. 
Representative cell-surface staining 
profiles from a pool of five positive ani-
mals (Fig. 2, c and d) were obtained by 
using two different staining reagents: the 
monoclonal antibody to SLA d previous-
Fig. 2. Cell-surface expression 
of SLA antigen in a transgenic 
mouse and its offspring. (a) 
PBL's from transgenic animal 
3931 examined for cell-surface 
expression of SLA antigen by 
flow microfluorometry (11). 
PBL's were incubated for 45 
minutes with biotin-conjugat-
ed, protein A-purified (12) 
monoclonal antibody to SLA 
(74-11-10) (6), counter-stained 
with fluorescein isothiocya-
nate-conjugated avidin (FITC-
avidin), and analyzed in a fluo-
rescence-activated cell sorter 
(FACS II; Becton Dickenson). 
Fluorescence data were col-
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viable cells and displayed at a lOOO-channel cell frequency histogram, in which log (fluorescence 
intensity) was plotted against cell number. The solid line represents the binding of biotinylated 
antibody 74-11-10; the broken line represents the binding of FITC-avidin alone. (b) Staining of 
PBL's from normal BIO animals as in (a). (c) Staining of a pool of PBL's from five progeny of 
animal 3931 with the biotinylated antibody 74-1 1-10 and counterstaining as in (a). (d) Staining of 
a pool of PBL's from five progeny of animal 3931 with an alloantiserum, 1920 (7), produced by 
immunizing an SLA ac pig with lymphocytes from an SLA dd animal. This serum was purified by 
affinity column chromatography on protein A-Sepharose, absorbed extensively with B 1 0 spleen 
cells to remove cross-reactive antibodies to mouse H-2, and directly conjugated with FITC (13). 
PBL's were incubated for 45 minutes and analyzed as in (a). The solid line represents the 
fluorescence of cells incubated with the FITC-Iabeled alloantiserum, and the broken line 
represents the fluorescence of unlabeled cells. The results are displayed on a log scale, where 
every 100 units represents approximately a twofold increase in the level of expression. 
Fig. 3. Identification of transgenic mice by genomic hybridization and 
determination of SLA gene stability and copy number. DNA samples 
(10 IJ.g) from two progeny of animal 3931 that were positive for the 
SLA gene as determined by dot hybridization (lanes 4 and 5) and from 
three animals that were negative (lanes I, 2, and 3) were digested with 
the restriction enzyme Sac I at a ratio of 15 U per microgram. Total 
pig DNA (10 IJ.g) was similarly digested (lane 6). Amounts of PDl 
DNA corresponding to I (0.2 ng, lane 9), 10 (2 ng, lane 8), and 50 (10 
ng, lane 7) copies of SLA gene per genome were added to 10 IJ.g of 
normal BIO DNA and digested with Sac I under the same conditions. 
DNA fragments were resolved by electrophoresis on 0.8 percent 
agarose gels in TPE [0.08M tris-phosphate, 8 mM EDTA (PH 7.6)] for 
24 hours at 30 V. DNA was transferred to nitrocellulose by the 
method of Southern (14). Hybridization was carried out with the SLA-
specific probe, labeled by nick-translation (15), in 40 percent forma-
mide, 10 percent dextran sulfate, 4x standard saline citrate (SSC), 
1 x Denhart solution, 20 IJ.g of salmon sperm DNA per milliliter, and 
10 IJ.g of Escherichia coli DNA for 24 hours at 42°C. The filter was 
washed two times in 2x SSC at room temperature for 30 minutes 
each, and two times in 0.1 x SSC at 65°C for 1 hour each. The posi-
tion of the hybridizing 3.4-kb Sac I fragment is noted. 
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ly used to characterize animal 3931 (Fig. 
2c) and a swine alloantiserum, haplotype 
ac antibodies to haplotype dd, which is 
specific for MHC antigens of the rele-
vant SLA d haplotype (7) and from which 
the PDl clone was derived (Fig. 2d). 
Both reagents specifically stained trans-
genic lymphocytes. The specificity of 
staining was confirmed by inhibition 
studies; the staining of the transgenic 
mouse lymphocytes by the biotin-conju-
gated monoclonal antibody to SLA could 
be blocked by unlabeled antibody to 
SLA but not by monoclonal antibody to 
H-2K (8), which binds to the H-2Kb 
molecule expressed on BIO PBL's. Re-
ciprocally, the binding of biotinylated 
antibody to H-2Kb could not be inhibited 
by antibody to SLA but was completely 
blocked by the unlabeled antibody to H-
2Kb. Therefore, both the SLA gene and 
the ability to express that gene were 
transmitted to the progeny. 
Because the results were concordant 
between DNA analysis and cell-surface 
expression, subsequent litters were test-
ed only by cell-surface staining. Of 65 
progeny of animal 3931 examined, 33 
(50.7 percent) expressed the SLA gene. 
This frequency of transmission suggests 
that a single genetic linkage group con-
taining the SLA gene is integrated into 
the mouse genome. Because both male 
and female positive offspring were iden-
tified, integration of the SLA gene into 
either the X or Y chromosome is unlike-
ly. 
The copy number and stability of the 
4 5 6 7 8 9 
- 3 .4kb 
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SLA gene were assessed further by ana-
lyzing restriction endonuclease digests 
of liver DNA from two representative 
SLA-positive mice compared with three 
negative littermates. After digestion with 
the enzyme Sac I, DNA samples were 
sUbjected to electrophoresis on agarose 
gels in parallel with various amounts of 
Sac I-digested PD1 DNA, corresponding 
to 1, 10, and 50 copies per haploid 
genome, as well as Sac I-digested total 
pig DNA. After transfer to nitrocellulose 
paper, the samples were hybridized with 
the SLA-specific probe (Fig. 1). Geno-
mic DNA from both positive transgenic 
mice and pig contained a single hybridiz-
ing band with the same mobility as the 
PDl band (Fig 3); no hybridizing bands 
were observed in the DNA samples of 
the negative littermates. These data sug-
gest that there are no major rearrange-
ments of the SLA genes in the progeny. 
By comparing the intensity of hybridiza-
tion of the probe to the transgenic mouse 
DNA with that of the various PD1 DNA 
samples, we estimated that there are one 
or a few copies of the SLA gene in each 
of the positive progeny. Taken together 
with the transmission frequency of SLA-
antigen expression, we conclude that, in 
the transgenic mice, the SLA gene is in a 
single integration site and is transmitted 
in accordance with Mendelian inheri-
tance. 
The expression of the SLA gene in 
various lymphoid tissues was examined 
next. Previous studies have indicated 
that expression of the PD1 SLA gene in 
mouse L cells appears to be actively 
regulated (4). Initial studies suggest that 
the PD1 SLA gene is differentially ex-
pressed in vivo in the pig (9). The pattern 
of SLA gene expression in the transgenic 
mice was analyzed by cell-surface stain-
ing with the monoclonal antibody to 
SLA d. For comparison, expression of 
the endogenous H-2Kb antigen was de-
termined in parallel with a monoclonal 
antibody specific for H-2Kb (8). The 
results indicated that the levels of 
expression of SLA antigen varied among 
different tissues in the transgenic mice 
(Fig. 4, a, c, and e). Namely, splenocytes 
expressed less surface SLA antigen than 
lymph node cells, which expressed less 
than bone marrow cells. In particular, 
two distinct subpopulations of cells were 
observed in the bone marrow with differ-
ent levels of cell-surface antigen expres-
sion. Similar analyses of thymocytes re-
vealed a weak level of SLA antigen on 
these cells as well. The expression of H-
2Kb also varied somewhat between the 
tissues examined (Fig. 4, b, d, and f), 
although there did not appear to be a 
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direct correlation with SLA expression. 
The fluorescence intensity of the H-2Kb 
antibody staining was consistently great-
er than that of the SLA antibody. It is 
not clear whether the differences in in-
tensity of staining of the two antibodies 
are due to quantitative differences be-
tween SLA and H-2Kb or to a lower 
affinity of the SLA antibody for SLA 
than of the H-2Kb antibody for H-2Kb. 
Staining of pig PBL's with the SLA 
antibody gave a fluorescence intensity 
similar to that observed with the H-2Kb 
antibody staining of mouse cells. Initial 
analysis of total RNA from various tis-
sues revealed tissue-specific variations 
in the levels of SLA RNA expression. 
These data suggest that SLA expression 
in transgenic mice may be regulated. 
Because antigenic determinants resi-
dent on the SLA gene product are ex-
pressed on the surface of transgenic 
mouse cells, it was next of interest to 
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antigen can be recognized by T cells as a 
classic transplantation antigen. 
Rejection of skin graft is one feature of 
T cell-mediated MHC recognition. The 
ability of the SLA antigen to be recog-
nized as a transplantation antigen was 
assessed by engrafting normal B 10 ani-
mals with tail skin from transgenic and 
normal B 10 mice. Rejection was scored 
as complete when no viable graft could 
be detected. None of the recipients 
(n = 10) rejected skin from normal B10 
animals; however, all the recipients 
(n = 8) rejected skin from transgenic 
mice, with a median survival time of 18 
days (Fig. 5). This rejection time is not 
significantly different from the rejection 
time of an allogeneic class I difference 
(10). 
It should now be possible to determine 
the relation between those T cells specif-
ic for xenogeneic MHC products and the 
T cells specific for syngeneic and alloge-
neic murine MHC determinants. In addi-
b 
d 
Fig. 4. Tissue distribution of 
SLA and H-2 antigens in 
transgenic mice. Cells from 
spleen (a and b), lymph node 
(c and d), and bone marrow (e 
and f) of a single animal, 3815, 
were stained with either a 
monoclonal antibody to SLA 
(74-11-10) (a, c, and e) or 
monoclonal antibody to H-
2Kb (28-13-3) (b, d, and f) and 
analyzed by flow microfluoro-
metry as described in the leg-
end to Fig. 2. Solid lines repre-
sent binding of the biotinylat-
ed antibody, and broken lines 
represent binding of the FITC-
avidin counterstain alone. 
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Fig. 5. Survival of skin 
from transgenic and nor-
mal B 10 mice grafted onto 
normal BIO mice. Skin 
grafts offull thickness were 
harvested from the tails of 
three transgenic mice and 
three normal BIO mice. 
Heterotopic grafting was 
performed as described 
(16); minimum follow-up 
time was 29 days. Graft 
survivals were calculated 
by the life-table method 
(17). The calculated medi-
an survival time of trans-
genic grafts (.) was 18 
days; that of normal BIO 
skin (0) was greater than 
70 days. 
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tion, the mechanisms mediating murine 
self-tolerance to the normally foreign 
SLA antigens can be compared with 
those involved in conventional self-toler-
ance to murine H-2 products. Finally, it 
will be of interest to determine the de-
gree to which the murine T cell reper-
toire can utilize a transfected SLA gene 
product as a restricting element for anti-
gen recognition and physiologic cell in-
teractions. 
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